Table 2 Clinical features of HIR < 0.4 patients and HIR ≥ 0.4 patients.
HIR<0.4 (n = 82) | HIR ≥ 0.4 (n = 19) | P | |
---|---|---|---|
Gender(male) (No.) (%) | 54(65.85%) | 13(68.42%) | 0.831 |
Age (mean ± SD) (yr) | 62.96 ± 11.28 | 61.74 ± 12.61 | 0.677 |
History of stroke/TIA (No.) (%) | 24(29.27%) | 7(36.84%) | 0.519 |
History of cerebral hemorrhage (No.) (%) | 2(2.44%) | 0 | 1 |
Hypertension (No.) (%) | 52(63.41%) | 13(68.42%) | 0.681 |
Diabetes (No.) (%) | 22(26.83%) | 7(36.84%) | 0.385 |
Hyperlipidemia (No.) (%) | 0 | 1(5.26%) | 0.188 |
Coronary heart disease (No.) (%) | 14(17.07%) | 4(21.05%) | 0.741 |
Atrial fibrillation (No.) (%) | 11(13.41%) | 3(15.79%) | 0.724 |
Smoking (No.) (%) | 26(31.71%) | 5(26.32%) | 0.646 |
Drinking (No.) (%) | 7(8.54%) | 1(5.26%) | 1 |
BMI (mean ± SD) | 24.08 ± 2.86 | 24 ± 3.12 | 0.912 |
HbA1c (median) (IQR) (%) | 6.10(5.70, 7.10) | 6.20(5.80, 6.70) | 0.667 |
TC (mean ± SD) (mmol/l) | 4.06 ± 1.05 | 3.84 ± 1.23 | 0.419 |
TG (median) (IQR) (mmol/l) | 1.23(0.95, 1.71) | 1.15(0.88, 1.34) | 0.203 |
HDL-C (mean ± SD) (mmol/l) | 1.04 ± 0.26 | 0.95 ± 0.36 | 0.234 |
LDL-C (mean ± SD) (mmol/l) | 2.50 ± 0.82 | 2.45 ± 0.95 | 0.836 |
HCY (median) (IQR) (umol/L) | 16.10(11.48, 23.48) | 15.50(10.80, 21.40) | 0.611 |
UA (median) (IQR) (umol/L) | 311.96 ± 86.85 | 278.67 ± 72.19 | 0.124 |
HGB (median) (IQR) (g/l) | 137.50(129.75, 146.25) | 142(127, 155) | 0.676 |
NIHSS (median) (IQR) | 6(3, 10) | 8(5, 14) | 0.076 |
TOAST classification | |||
Cardioembolism | 11(13.41%) | 3(15.79%) | 0.724 |
Large-artery atherosclerosis (LAA) | 71(86.59%) | 16(84.21%) | |
Occluded Vessel | 0.643 | ||
ICA | 12(14.63%) | 3(15.79%) | |
ICA and MCA simultaneously occluded | 8(9.76%) | 3(15.79%) | |
MCA | 62(75.61%) | 13(68.42%) | |
APOE genotype | 0.009 | ||
ε2/ε3 | 9(10.98%) | 0 | |
ε3/ε3 | 63(76.83%) | 11(57.89%) | |
ε3/ε4 | 9(10.98%) | 8(42.11%) | |
ε4/ε4 | 1(1.22%) | 0 | |
APOE genotype | 0.013 | ||
ε3/ε3 | 63(86.30%) | 11(57.89%) | |
ε3/ε4 | 9(12.33%) | 8(42.11%) | |
ε4/ε4 | 1(1.37%) | 0(0%) | |
APOE genotype | 0.006 | ||
non-ε4 carriers | 72(87.80%) | 11(57.89%) | |
ε4 carriers | 10(12.20%) | 8(42.11%) | |
IC volume (median) (IQR) (ml) | 40.00(19.93, 69.47) | 90.50(27.00, 176.00) | 0.004 |
ischemic penumbra volume (mean ± SD) (ml) | 130.52 ± 70.02 | 164.04 ± 93.17 | 0.081 |